SYSTEMIC ABSORPTION OF METRONIDAZOLE BY THE VAGINAL ROUTE
- 1 January 1985
- journal article
- research article
- Vol. 65 (6) , 781-784
Abstract
A study was designed to compare the systemic absorption of metronidazole by the oral and vaginal routes. Nine subjects received single 500 mg doses of the oral, vaginal insert and vaginal cream preparations on 3 occasions. Approximately 20% bioavailability was demonstrated from both vaginal forms. Mean peak plasma concentrations were 15.56 .mu.g/ml for the oral form, 1.86 .mu.g/ml for the cream and 1.89 .mu.g/ml for the insert. The mean times to peak concentration were 1.23 h for the oral dose and 11.11 h and 20.11 h for the cream and insert, respectively. Apparently, some vaginal absorption occurs from both the cream and insert preparations of metronidazole.This publication has 14 references indexed in Scilit:
- INTRAVENOUS METRONIDAZOLE OR CLINDAMYCIN WITH TOBRAMYCIN FOR THERAPY OF PELVIC INFECTIONS1981
- Metronidazole for vaginal trichomoniasis. Seven-day vs single-dose regimensJAMA, 1980
- PHARMACOKINETICS AND METABOLIC DISPOSITION OF C-14-METRONIDAZOLE-DERIVED RADIOACTIVITY IN RAT AFTER INTRAVENOUS AND INTRA-VAGINAL ADMINISTRATION1980
- SINGLE-DOSE METRONIDAZOLE TREATMENT FOR VAGINAL TRICHOMONIASIS1980
- Lack of Evidence for Cancer Due to Use of MetronidazoleNew England Journal of Medicine, 1979
- The disposition of [14C]metronidazole in rats following vaginal and oral administrationJournal of Pharmacy and Pharmacology, 1979
- Nonspecific VaginitisNew England Journal of Medicine, 1978
- Single dose of two grams of metronidazole for Trichomonas vaginalis infectionAmerican Journal of Obstetrics and Gynecology, 1977
- A new approach to patients with suspected anaerobic postpartum pelvic infections. Transabdominal uterine aspiration for culture and metronidazole for treatmentAmerican Journal of Obstetrics and Gynecology, 1976
- UROGENITAL TRICHOMONIASIS1964